Literature DB >> 272224

Analysis of treatment in childhood leukemia. IV. The critical association between dose fractionation and immunosuppression induced by cranial irradiation.

I C MacLennan, H E Kay.   

Abstract

The degree of long term lymphopenia induced by cranial irradiation is shown to be dependent upon the number of fractions into which the standard cranial dose of 2400 rads is divided. The mean lymphocyte count of patients three months after receiving this dose in five fractions was 1.84 X 10(9)/1; in twelve fractions it was 1.12 X 10(9)/1 and in twenty fractions it was 0.64 X 10(9)/1. An explanation for this finding is offered which is based upon marked radiosensitivity of certain lymphocytes and the pattern of recirculation and redistribution of these cells.

Entities:  

Mesh:

Year:  1978        PMID: 272224     DOI: 10.1002/1097-0142(197801)41:1<108::aid-cncr2820410116>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

1.  Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy.

Authors:  Alexander J Lin; Jian L Campian; Caressa Hui; Soumon Rudra; Yuan J Rao; Dinesh Thotala; Dennis Hallahan; Jiayi Huang
Journal:  J Neurooncol       Date:  2017-11-16       Impact factor: 4.130

Review 2.  Neural stem cells, the subventricular zone and radiotherapy: implications for treating glioblastoma.

Authors:  Andrew W Smith; Minesh P Mehta; A Gabriella Wernicke
Journal:  J Neurooncol       Date:  2016-04-23       Impact factor: 4.130

Review 3.  Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma.

Authors:  Russell Maxwell; Christopher M Jackson; Michael Lim
Journal:  Curr Treat Options Oncol       Date:  2017-08

Review 4.  Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas.

Authors:  Susannah Yovino; Stuart A Grossman
Journal:  CNS Oncol       Date:  2012-11

5.  Haematological toxicity of Valproic acid compared to Levetiracetam in patients with glioblastoma multiforme undergoing concomitant radio-chemotherapy: a retrospective cohort study.

Authors:  Alexander Tinchon; Stefan Oberndorfer; Christine Marosi; Andreas Gleiss; Angelika Geroldinger; Cornelia Sax; Camillo Sherif; Walter Moser; Wolfgang Grisold
Journal:  J Neurol       Date:  2014-10-31       Impact factor: 4.849

6.  Lymphopenia and its association with survival in patients with locally advanced cervical cancer.

Authors:  Emily S Wu; Titilope Oduyebo; Lauren P Cobb; Diana Cholakian; Xiangrong Kong; Amanda N Fader; Kimberly L Levinson; Edward J Tanner; Rebecca L Stone; Anna Piotrowski; Stuart Grossman; Kara Long Roche
Journal:  Gynecol Oncol       Date:  2015-11-11       Impact factor: 5.482

7.  The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells.

Authors:  Susannah Yovino; Lawrence Kleinberg; Stuart A Grossman; Manisha Narayanan; Eric Ford
Journal:  Cancer Invest       Date:  2013-02       Impact factor: 2.176

8.  4D blood flow model for dose calculation to circulating blood and lymphocytes.

Authors:  Abdelkhalek Hammi; Harald Paganetti; Clemens Grassberger
Journal:  Phys Med Biol       Date:  2020-03-02       Impact factor: 3.609

9.  Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy.

Authors:  Yutaka Shiraishi; Penny Fang; Cai Xu; Juhee Song; Sunil Krishnan; Eugene J Koay; Reza J Mehran; Wayne L Hofstetter; Mariela Blum-Murphy; Jaffer A Ajani; Ritsuko Komaki; Bruce Minsky; Radhe Mohan; Charles C Hsu; Brian P Hobbs; Steven H Lin
Journal:  Radiother Oncol       Date:  2017-12-14       Impact factor: 6.280

Review 10.  Assessing the interactions between radiotherapy and antitumour immunity.

Authors:  Clemens Grassberger; Susannah G Ellsworth; Moses Q Wilks; Florence K Keane; Jay S Loeffler
Journal:  Nat Rev Clin Oncol       Date:  2019-06-26       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.